Pulmocide

Biopharmaceutical company developing novel inhaled therapies for patients suffering from serious acute and chronic respiratory diseases, with a focus on pulmonary fungal infections.

Location
London, United Kingdom
Founded
2013
Investors
1
Categories
biotech, respiratory, antifungal, pulmonary-infections

Investors

NameLocationTypeStagesPortfolio
Adjuvant CapitalWashington, DC, USAbiotech-focused
seedseries-a+3
16